|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2008-6-3
|
|
pubmed:abstractText |
Galectin-9 (Gal-9) induces adhesion and aggregation of certain cell types and can be a prognostic factor in the patients with melanoma and breast cancer. We assessed the experiments to resolve whether Gal-9 expression in cervical neoplasm links to malignant potential of cervical squamous cell carcinoma (SCC) cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1432-1335
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
134
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
899-907
|
|
pubmed:dateRevised |
2009-3-17
|
|
pubmed:meshHeading |
pubmed-meshheading:18264727-Adult,
pubmed-meshheading:18264727-Aged,
pubmed-meshheading:18264727-Cadherins,
pubmed-meshheading:18264727-Carcinoma, Squamous Cell,
pubmed-meshheading:18264727-Cervical Intraepithelial Neoplasia,
pubmed-meshheading:18264727-Female,
pubmed-meshheading:18264727-Galectins,
pubmed-meshheading:18264727-Humans,
pubmed-meshheading:18264727-Immunohistochemistry,
pubmed-meshheading:18264727-Middle Aged,
pubmed-meshheading:18264727-Prognosis,
pubmed-meshheading:18264727-Tumor Markers, Biological,
pubmed-meshheading:18264727-Uterine Cervical Neoplasms
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma.
|
|
pubmed:affiliation |
Department of Immunology and Immunopathology, Faculty of Medicine, Kagawa University, Kagawa, 761-0793, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
